The Influence of Finasteride on the Development of Prostate Cancer
New England Journal of Medicine2003Vol. 349(3), pp. 215–224
Citations Over TimeTop 1% of 2003 papers
Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, M. Scott Lucia, Gary J. Miller, Leslie G. Ford, Michael M. Lieber, R. Duane Cespedes, J. Atkins, Scott M. Lippman, Susie M. Carlin, Anne Ryan, Connie M. Szczepanek, John Edwards, Charles A. Coltman
Abstract
Finasteride prevents or delays the appearance of prostate cancer, but this possible benefit and a reduced risk of urinary problems must be weighed against sexual side effects and the increased risk of high-grade prostate cancer.
Related Papers
- → Influence of prostate volume in the detection of prostate cancer(2003)47 cited
- → Can effect of finasteride on prostate-specific antigen be used to decrease repeat prostate biopsy?(2006)12 cited
- → The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma(1994)27 cited
- → Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen(1996)66 cited
- → Castration-like effects on the human prostate of a 5α-reductase inhibitor, finasteride(1992)23 cited